Humans with function-disrupting variants in the myostatin gene (MSTN) have increased skeletal muscle mass and strength, and less adiposity

Journal:
Nature Communications
Published:
DOI:
10.1038/s41467-026-70422-2
Affiliations:
6
Authors:
20
Go to article
Institutions Authors Share
Regeneron Pharmaceuticals, United States of America (USA)
19.000000
19.000000
 0.95
Lund University (LU), Sweden
0.500000
 0.03
Skåne University Hospital (SUS), Sweden
0.500000
 0.03
Interested in Animal Production?